1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics 2020 - United States (p9)

Biotechnology Analysis & Statistics 2020 - United States (p9)

241-270 of about 400 reports

Fibromyalgia (Fibromyalgia Syndrome) - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 131 pages

Fibromyalgia (Fibromyalgia Syndrome) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Pipeline Review, H2 2020, provides an overview of ...

  • Biotechnology
  • Chronic Pain
  • Pharmaceutical
  • Therapy
  • United States

Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 76 pages

Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Lysosomal alpha-glucosidase is an enzyme encoded ...

  • Biotechnology
  • Therapy
  • United States
  • Product Initiative
  • Amicus Therapeutics

Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 273 pages

Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - JAK1 is a human tyrosine kinase protein essential for signaling fo ...

  • Biotechnology
  • Dermatological Condition
  • Pharmaceutical
  • Therapy
  • United States

Fibroblast Growth Factor Receptor 4 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 165 pages

Fibroblast Growth Factor Receptor 4 - Pipeline Review, H2 2020 Summary Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Fibroblast growth factor receptor 4 is a protein encoded by ...

  • Biotechnology
  • Cell Therapy
  • Hospital
  • Therapy
  • United States

Caspase 3 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 80 pages

Caspase 3 - Pipeline Review, H2 2020 Summary Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to 10 ...

  • Biotechnology
  • Chemotherapy
  • Therapy
  • United States
  • World

Beta Nerve Growth Factor - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 61 pages

Beta Nerve Growth Factor - Pipeline Review, H2 2020 Summary Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 10 molecules. The latest report Beta Nerve Growth Factor - Pipeline ...

  • Biotechnology
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • United States

Vascular Endothelial Growth Factor B - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 65 pages

Vascular Endothelial Growth Factor B - Pipeline Review, H2 2020 Summary According to the recently published report ’Vascular Endothelial Growth Factor B - Pipeline Review, H2 2020’; Vascular Endothelial ...

  • Biosimilar
  • Biotechnology
  • Medical Biotechnology
  • United States
  • Product Initiative

Phenylalanine 4 Hydroxylase - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 56 pages

Phenylalanine 4 Hydroxylase - Pipeline Review, H2 2020 Summary Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) pipeline Target constitutes close to 8 molecules. The latest report ...

  • Biotechnology
  • Endocrine Disease
  • Gene Therapy
  • Therapy
  • United States

Atypical Hemolytic Uremic Syndrome - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 128 pages

Atypical Hemolytic Uremic Syndrome - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Atypical Hemolytic Uremic Syndrome - Pipeline Review, H2 2020, provides ...

  • Biotechnology
  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • United States

Interleukin 1 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 156 pages

Interleukin 1 - Pipeline Review, H2 2020 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 30 molecules. Out of which approximately 29 molecules are developed by companies and remaining ...

  • Biotechnology
  • Protein Therapy
  • Therapy
  • United States
  • Product Initiative

Transforming Growth Factor Beta 1 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 102 pages

Transforming Growth Factor Beta 1 - Pipeline Review, H2 2020 Summary Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor beta 1 (TGF-?1) is a polypeptide member of the transforming ...

  • Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • United States

Toll Like Receptor 8 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 96 pages

Toll Like Receptor 8 - Pipeline Review, H2 2020 Summary Toll Like Receptor 8 (CD288 or TLR8) pipeline Target constitutes close to 26 molecules. Out of which approximately 25 molecules are developed by ...

  • Biotechnology
  • Pharmaceutical
  • Therapy
  • United States
  • Bristol-Myers Squibb Company

Dilated Cardiomyopathy - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 66 pages

Dilated Cardiomyopathy - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H2 2020, provides an overview of the ...

  • Biotechnology
  • Cardiovascular Disease
  • Hospital
  • Therapy
  • United States

Phenylketonuria (PKU) - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 80 pages

Phenylketonuria (PKU) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria - Pipeline Review, H2 2020, provides an overview of the Phenylketonuria ...

  • Biotechnology
  • Endocrine Disease
  • Therapy
  • United States
  • Product Initiative

Intermittent Claudication - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 57 pages

Intermittent Claudication - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Intermittent Claudication - Pipeline Review, H2 2020, provides an overview ...

  • Biotechnology
  • Therapy
  • United States
  • Product Initiative
  • Pluristem Therapeutics Inc.

Myasthenia Gravis - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 254 pages

Myasthenia Gravis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Pipeline Review, H2 2020, provides an overview of the Myasthenia ...

  • Biotechnology
  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • United States

Degenerative Disc Disease - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 72 pages

Degenerative Disc Disease - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Pipeline Review, H2 2020, provides an overview ...

  • Biotechnology
  • Cell Therapy
  • Therapy
  • United States
  • Bone Therapeutics SA

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 152 pages

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020, provides ...

  • Biotechnology
  • Chemotherapy
  • Monoclonal Antibody
  • Pharmaceutical
  • United States

Anthrax - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 126 pages

Anthrax - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Pipeline Review, H2 2020, provides an overview of the Anthrax (Infectious Disease) ...

  • Biotechnology
  • Infectious Disease
  • Therapy
  • Vaccine
  • United States

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 66 pages

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Microscopic Polyangiitis - Pipeline Review, H2 2020, provides an overview ...

  • Autoimmune Disease
  • Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States

Obsessive-Compulsive Disorder - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 60 pages

Obsessive-Compulsive Disorder - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Obsessive-Compulsive Disorder - Pipeline Review, H2 2020, provides an ...

  • Biotechnology
  • Personality Disorder
  • Pharmaceutical
  • Therapy
  • United States

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 419 pages

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis - Pipeline Review, H2 2020, provides an overview ...

  • Autoimmune Disease
  • Biotechnology
  • Dermatological Condition
  • Musculoskeletal Disorder
  • United States

Diabetic Macular Edema - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 319 pages

Diabetic Macular Edema - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Macular Edema - Pipeline Review, H2 2020, provides an overview of the ...

  • Biotechnology
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • United States

Ischemia Reperfusion Injury - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 197 pages

Ischemia Reperfusion Injury - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ischemia Reperfusion Injury - Pipeline Review, H2 2020, provides an overview ...

  • Biotechnology
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Traumatic Brain Injury - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 440 pages

Traumatic Brain Injury - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2020, provides an overview of the ...

  • Biotechnology
  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • United States

Colitis - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 116 pages

Colitis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H2 2020, provides an overview of the Colitis (Gastrointestinal) pipeline ...

  • Biotechnology
  • Digestive System Disorder
  • Therapy
  • United States
  • Soligenix, Inc.

Warts - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 112 pages

Warts - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Warts - Pipeline Review, H2 2020, provides an overview of the Warts (Infectious Disease) pipeline ...

  • Biotechnology
  • Dermatological Condition
  • United States
  • Product Initiative
  • Aclaris Therapeutics, Inc.

House Dust Mite Allergy - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 61 pages

House Dust Mite Allergy - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H2 2020, provides an overview of ...

  • Allergy
  • Allergy Immunotherapy
  • Biotechnology
  • United States
  • Anergis SA

Amyloidosis - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 241 pages

Amyloidosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2020, provides an overview of the Amyloidosis (Metabolic ...

  • Biotechnology
  • Endocrine Disease
  • Monoclonal Antibody
  • United States
  • Alnylam Pharmaceuticals, Inc.

Alopecia - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 222 pages

Alopecia - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Pipeline Review, H2 2020, provides an overview of the Alopecia (Dermatology) pipeline ...

  • Biotechnology
  • Hair Growth
  • Pharmaceutical
  • United States
  • Product Initiative

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on